Skip to content

Dietary intervention trial: single blinded placebo-controlled, randomized study to assess anti-diabetic effects of daily bitter gourd consumption among pre-diabetics in Moshi, Tanzania

Dietary intervention trial: single blinded placebo-controlled, randomized study to assess anti-diabetic effects of daily bitter gourd consumption among pre-diabetics in Moshi, Tanzania - MOCHI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005131
Enrollment
90
Registered
2013-07-24
Start date
2013-07-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-diabetes

Interventions

Group 1: Bitter gourd sachets: Bitter gourd powder (g): 2.5 Cucumber powder (g): 0.75 Alpha-cyclodextrin* (g): 0.75 Beta-cyclodextrin (mg): 75 Steviol glycoside (mg): 15 Total (g) 4.090 *containing 2

Sponsors

Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung (BMZ)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: - BMI > 27 - 80 cm (women) > 94 cm (men) - Being pre-diabetic according to: - Fasting plasmae glucose (FPG) = 100 – 125 mg/dl (= 5.6 – 6.9 mmol/l) on two screening days or FPG = 100 – 125 mg/dl and HbA1c = 5.7% < 6.5% on one screening day

Exclusion criteria

Exclusion criteria: - Having diagnosed disease - Having G6PD deficiency - Taking any kind of medication regularly - High blood pressure (>140/>90) - Low blood pressure (<90/<60) - Being mentally ill - Pregnancy or planned pregnancy - Breast-feeding - Heavy alcohol consumption

Design outcomes

Primary

MeasureTime frame
Fasting plasma glucose: measured each at baseline and after each intervention of eight weeks (end assessment) as well as during the weekly check-ups.

Secondary

MeasureTime frame
HbA1c, insulin, triglycerides, high-density lipoprotein, cholesterol:measured each at baseline and after each intervention of eight weeks (end assessment) Body weight, waist circumference, blood pressure: measured each at baseline and after each intervention of eight weeks (end assessment) as well as during the weekly check-ups.

Countries

Tanzania

Contacts

Public ContactChristine Ludwig

Justus-Liebig Universität Gießen, Institut für Ernährungswissenschaft - Ernährung in Entwicklungsländern

christine.ludwig@ernaehrung.uni-giessen.de+49 641 99 39036

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026